Lataa...
Two cases of recurrent ovarian clear cell carcinoma treated with sorafenib
Sorafenib is an oral multikinase inhibitor targeting Raf and other kinases. The anti-tumor effect of sorafenib is thought to be mediated through its inhibition of the RAS–Raf–Erk pathway, as well as its inhibition of VEGFR and PDGFR. Sorafenib has been effective at treating patients with renal cell...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3938519/ https://ncbi.nlm.nih.gov/pubmed/24096267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.26608 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|